UGT1A3与性别是替米沙坦药代动力学的主要决定因素
该研究在188名健康志愿者中给予单剂替米沙坦40 mg,并对379个药代动力学基因测序,发现UGT1A3*2等位基因与替米沙坦AUC0-∞和Cmax降低显著相关,且男性血药浓度低于女性;基因型评分与替米沙坦对舒张压的效应相关。
要点
- UGT1A3*2是替米沙坦暴露降低的主要遗传因素。
- 男性替米沙坦血浆浓度低于女性。
- 性别与遗传变异的基因型评分与替米沙坦降压效应相关。
核心结论
- 性别和UGT1A3是替米沙坦药代动力学的主要决定因素,并提示OATP1B3可能参与其中。
研究设计与样本
- 在188名健康志愿者中给予单剂替米沙坦40 mg,测定药代动力学并对379个基因测序。
主要发现
- UGT1A3*2杂合和纯合男性替米沙坦AUC0-∞分别降低64%(P=1.21×10-16)和63%(P=5.21×10-8)。
- UGT1A3*2杂合和纯合女性替米沙坦AUC0-∞分别降低57%(P=1.54×10-11)和72%(P=3.31×10-15)。
- 候选基因分析提示UGT1A3*3和SLCO1B3 c.767G>C错义变异与替米沙坦药代动力学相关。
- 反映性别和遗传变异对替米沙坦AUC0-∞影响的基因型评分与替米沙坦对舒张压的效应相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To investigate how variability in multiple pharmacokinetic genes associates with telmisartan exposure, we determined telmisartan single-dose (40 mg) pharmacokinetics and sequenced 379 genes in 188 healthy volunteers. Intronic UGT1A variants showed the strongest associations with the area under the plasma concentration-time curve from zero hours to infinity (AUC0-∞ ) and peak plasma concentration (Cmax ) of telmisartan. These variants were strongly linked with the increased function UGT1A3*2 allele, suggesting that it is the causative allele underlying these associations. In addition, telmisartan plasma concentrations were lower in men than in women. The UGT1A3*2 was associated with a 64% and 63% reduced AUC0-∞ of telmisartan in UGT1A3*2 heterozygous and homozygous men, respectively (P = 1.21 × 10-16 and 5.21 × 10-8 ). In women, UGT1A3*2 heterozygosity and homozygosity were associated with 57% (P = 1.54 × 10-11 ) and 72% (P = 3.31 × 10-15 ) reduced AUC0-∞ , respectively. Furthermore, a candidate gene analysis suggested an association of UGT1A3*3 and the SLCO1B3 c.767G>C missense variant with telmisartan pharmacokinetics. A genotype score, which reflects the effects of sex and genetic variants on telmisartan AUC0-∞ , associated with the effect of telmisartan on diastolic blood pressure. These data indicate that sex and UGT1A3 are major determinants and suggest a role for OATP1B3 in telmisartan pharmacokinetics.
引用
- Hirvensalo P, Tornio A, Launiainen T, et al. UGT1A3 and Sex Are Major Determinants of Telmisartan Pharmacokinetics-A Comprehensive Pharmacogenomic Study. Clin Pharmacol Ther. 2020. PMID: 32498119. doi:10.1002/cpt.1928
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。